These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 316679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K, Petersson M, Ciupitu AM, Wen T, Klein G, Kiessling R.
    Cancer Res; 1995 Dec 01; 55(23):5648-55. PubMed ID: 7585649
    [Abstract] [Full Text] [Related]

  • 5. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM, Nelson DL, Strober W, Bundy DM, Jones EA.
    J Clin Invest; 1977 Nov 01; 60(5):1116-28. PubMed ID: 332716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
    Bubeník J, Indrová M, Malkovský M, Símová J.
    Arch Geschwulstforsch; 1981 Nov 01; 51(4):349-53. PubMed ID: 6172086
    [Abstract] [Full Text] [Related]

  • 9. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1983 Nov 01; 43(11):5120-5. PubMed ID: 6604572
    [Abstract] [Full Text] [Related]

  • 10. Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma.
    Ferry BL, Flannery GR, Robins RA, Lawry J, Baldwin RW.
    Immunology; 1984 Oct 01; 53(2):243-50. PubMed ID: 6490084
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M, Bubeník J.
    Folia Biol (Praha); 1979 Oct 01; 25(2):137-41. PubMed ID: 456694
    [Abstract] [Full Text] [Related]

  • 12. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S.
    Cancer Res; 1986 Mar 01; 46(3):1047-54. PubMed ID: 3510719
    [Abstract] [Full Text] [Related]

  • 13. FcR+ lymphocytes and ADCC in tumor-bearing adult and aging rats.
    Nowak JJ, Ziółkowska M, Ryzewska A.
    Arch Immunol Ther Exp (Warsz); 1988 Mar 01; 36(1):45-53. PubMed ID: 3233063
    [Abstract] [Full Text] [Related]

  • 14. Activity of lymphocytes and antibodies derived from aging and adult rats bearing a MC-induced tumor in the syngeneic ADCC test.
    Nowak JJ, Ziółkowska M, Ryzewska A.
    Neoplasma; 1987 Mar 01; 34(6):703-11. PubMed ID: 3431610
    [Abstract] [Full Text] [Related]

  • 15. Membrane phenotype of the rat cytotoxic T lymphocyte.
    Gilman SC, Rosenberg JS, Feldman JD.
    J Immunol; 1982 Sep 01; 129(3):1012-6. PubMed ID: 6980913
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
    Fernandez-Cruz E, Gilman SC, Feldman JD.
    J Immunol; 1982 Mar 01; 128(3):1112-7. PubMed ID: 6460058
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B, Fossum S.
    Immunology; 1987 Feb 01; 60(2):151-7. PubMed ID: 2434415
    [Abstract] [Full Text] [Related]

  • 18. Chemical enhancement of tumor immunogenicity.
    Eggers AE, Hibbard CA, Civin CI, Wunderlich JR.
    J Immunol; 1980 Oct 01; 125(4):1737-44. PubMed ID: 6967915
    [Abstract] [Full Text] [Related]

  • 19. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R, Duffy T.
    J Immunol; 1985 Jun 01; 134(6):4255-60. PubMed ID: 3872913
    [Abstract] [Full Text] [Related]

  • 20. [Cytotoxic lymphocytes after allostimulation in vivo: kinetic, reproducibility and specificity after primary stimulation (author's transl)].
    Schulze HA, Brock J, Siegl E, Günther J.
    Allerg Immunol (Leipz); 1980 Jun 01; 26(4):310-8. PubMed ID: 6452040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.